WALKER WAYNE REMELL 4
4 · PharmaCyte Biotech, Inc. · Filed Jul 17, 2024
Insider Transaction Report
Form 4
WALKER WAYNE REMELL
Director
Transactions
- Award
Stock Option (Right to Buy)
2024-04-30+38,009→ 38,009 totalExercise: $2.12Exp: 2034-04-30→ Common Stock (38,009 underlying)
Footnotes (1)
- [F1]The options shall vest in full on the date of the Issuer's next annual meeting of stockholders, subject to the continued service of Mr. Walker. This transaction is late due to an inadvertent administrative error and not any error of Mr. Walker.